NDC | 63868-293-24 |
Set ID | aa1b43d1-f052-4520-b3c9-0619ab27ff7d |
Category | HUMAN OTC DRUG LABEL |
Packager | Chain Drug Marketing Association |
Generic Name | |
Product Class | |
Product Number | |
Application Number |
- Active ingredient (in each tablet)
- Purpose
- Warnings
- Ask doctor before use if you have
- When using this product
- Stop use and ask doctor if
- If pregnant or breast feeding,
- Keep out of reach of children
- Use
- Inactive ingredients
- Directions
- PRINCIPAL DISPLAY PANEL
-
INGREDIENTS AND APPEARANCE
QUALITY CHOICE URINARY PAIN RELIEF MAXIMUM STRENGTH
phenazopyridine hydrochloride tabletProduct Information Product Type HUMAN OTC DRUG Item Code (Source) NDC:63868-293 Route of Administration ORAL Active Ingredient/Active Moiety Ingredient Name Basis of Strength Strength PHENAZOPYRIDINE HYDROCHLORIDE (UNII: 0EWG668W17) (PHENAZOPYRIDINE - UNII:K2J09EMJ52) PHENAZOPYRIDINE HYDROCHLORIDE 97.5 mg Inactive Ingredients Ingredient Name Strength LACTOSE (UNII: J2B2A4N98G) MAGNESIUM SILICATE (UNII: 9B9691B2N9) Product Characteristics Color brown Score no score Shape ROUND Size 7mm Flavor Imprint Code P97 Contains Packaging # Item Code Package Description Marketing Start Date Marketing End Date 1 NDC:63868-293-24 2 in 1 CARTON 03/31/2017 1 12 in 1 BLISTER PACK; Type 0: Not a Combination Product Marketing Information Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date unapproved drug other 01/15/2015 Labeler - Chain Drug Marketing Association (011920774) Registrant - Reese Pharmaceutical Co (004172052) Establishment Name Address ID/FEI Business Operations Reese Pharmaceutical Co 004172052 relabel(63868-293) , repack(63868-293)